Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B

Background: There is no consensus for the best treatment of complex cutaneous leishmaniasis (CL). We aimed to describe a cohort of CL, focusing on liposomal amphotericin B (L-AmB) treatment outcome. Methods: We performed a retrospective study in Vall d’Hebron University Hospital (Barcelona, Spain)....

Descripción completa

Detalles Bibliográficos
Autores principales: Ubals, Maria, Bosch-Nicolau, Pau, Sánchez-Montalvá, Adrián, Salvador, Fernando, Aparicio-Español, Gloria, Sulleiro, Elena, Silgado, Aroa, Soriano-Arandes, Antoni, Espiau, Maria, Ferrer, Berta, Pou, Diana, Treviño, Begoña, Molina, Israel, García-Patos, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537943/
https://www.ncbi.nlm.nih.gov/pubmed/34684202
http://dx.doi.org/10.3390/pathogens10101253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537943/
https://www.ncbi.nlm.nih.gov/pubmed/34684202
http://dx.doi.org/10.3390/pathogens10101253

Ejemplares similares